283 related articles for article (PubMed ID: 26708225)
41. How to perform transcaval access and closure for transcatheter aortic valve implantation.
Lederman RJ; Babaliaros VC; Greenbaum AB
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1242-54. PubMed ID: 26356244
[TBL] [Abstract][Full Text] [Related]
42. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
[TBL] [Abstract][Full Text] [Related]
43. Surgical Management of Percutaneous Transfemoral Access to Minimize Vascular Complications Related to Transcatheter Aortic Valve' Implantation.
Lareyre F; Raffort J; Dommerc C; Habib Y; Bourlon F; Mialhe C
Angiology; 2018 Feb; 69(2):143-150. PubMed ID: 28569069
[TBL] [Abstract][Full Text] [Related]
44. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach".
Schäfer U; Ho Y; Frerker C; Schewel D; Sanchez-Quintana D; Schofer J; Bijuklic K; Meincke F; Thielsen T; Kreidel F; Kuck KH
JACC Cardiovasc Interv; 2012 May; 5(5):477-486. PubMed ID: 22625184
[TBL] [Abstract][Full Text] [Related]
45. Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.
Katz M; Carlos Bacelar Nunes Filho A; Caixeta A; Antonio Carvalho L; Sarmento-Leite R; Alves Lemos Neto P; Eduardo Koenig São Thiago L; Dias Dourado Oliveira A; Antonio Marino M; Tadeu Tumelero R; Antonio Perin M; Abizaid A; Tarasoutchi F; Sândoli de Brito F;
Catheter Cardiovasc Interv; 2017 Feb; 89(3):429-436. PubMed ID: 27468953
[TBL] [Abstract][Full Text] [Related]
46. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
Eggebrecht H; Schäfer U; Treede H; Boekstegers P; Babin-Ebell J; Ferrari M; Möllmann H; Baumgartner H; Carrel T; Kahlert P; Lange P; Walther T; Erbel R; Mehta RH; Thielmann M
JACC Cardiovasc Interv; 2011 Nov; 4(11):1218-27. PubMed ID: 22115663
[TBL] [Abstract][Full Text] [Related]
47. Surgical cutdown versus percutaneous access in transfemoral transcatheter aortic valve implantation: Insights from the Brazilian TAVI registry.
Bernardi FL; Gomes WF; de Brito FS; Mangione JA; Sarmento-Leite R; Siqueira D; Carvalho LA; Tumelero R; Guerios EE; Lemos PA
Catheter Cardiovasc Interv; 2015 Sep; 86(3):501-5. PubMed ID: 25586633
[TBL] [Abstract][Full Text] [Related]
48. Complete percutaneous approach versus surgical access in transfemoral transcatheter aortic valve implantation: results from a multicentre registry.
Kochman J; Kołtowski Ł; Huczek Z; Rymuza B; Wilimski R; Dąbrowski M; Witkowski A; Grygier M; Olasińska-Wiśniewska A; Kubler P; Reczuch K; Parma R; Ochała A; Jagielak D; Kochman W; Grube E
Kardiol Pol; 2018; 76(1):202-208. PubMed ID: 29131296
[TBL] [Abstract][Full Text] [Related]
49. Transcatheter Aortic Valve Implantation in Patients at Extremely High Risk of Perioperative Mortality.
Goebel N; Ahad S; Schaeufele T; Hill S; Beyer M; Berroth R; Franke UF; Baumbach H
J Heart Valve Dis; 2015 Sep; 24(5):635-9. PubMed ID: 26897844
[TBL] [Abstract][Full Text] [Related]
50. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
Abu Saleh WK; Tang GH; Ahmad H; Cohen M; Undemir C; Lansman SL; Reyes M; Barker CM; Kleiman NS; Reardon MJ; Ramlawi B
Catheter Cardiovasc Interv; 2016 Jul; 88(1):135-43. PubMed ID: 26603266
[TBL] [Abstract][Full Text] [Related]
51. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation.
Van Mieghem NM; Tchetche D; Chieffo A; Dumonteil N; Messika-Zeitoun D; van der Boon RM; Vahdat O; Buchanan GL; Marcheix B; Himbert D; Serruys PW; Fajadet J; Colombo A; Carrié D; Vahanian A; de Jaegere PP
Am J Cardiol; 2012 Nov; 110(9):1361-7. PubMed ID: 22819428
[TBL] [Abstract][Full Text] [Related]
52. Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access.
Ussia GP; Cammalleri V; Marchetti AA; Sarkar K; De Vico P; Muscoli S; Sergi D; Marchei M; Ippoliti A; Romeo F
J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):271-8. PubMed ID: 25036268
[TBL] [Abstract][Full Text] [Related]
53. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
[TBL] [Abstract][Full Text] [Related]
54. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM
Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053
[TBL] [Abstract][Full Text] [Related]
55. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
[TBL] [Abstract][Full Text] [Related]
56. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
[TBL] [Abstract][Full Text] [Related]
57. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
Sedaghat A; Sinning JM; Werner N
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E613-6. PubMed ID: 23460472
[TBL] [Abstract][Full Text] [Related]
58. Complications of the access during aortic valve implantation through transfemoral access.
Alsac JM; Zegdi R; Blanchard D; Achouh P; Cholley B; Berrebi A; Julia P; Fabiani JN
Ann Vasc Surg; 2011 Aug; 25(6):752-7. PubMed ID: 21621377
[TBL] [Abstract][Full Text] [Related]
59. Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.
Debry N; Sudre A; Amr G; Delhaye C; Schurtz G; Montaigne D; Koussa M; Modine T
Catheter Cardiovasc Interv; 2016 Mar; 87(4):797-804. PubMed ID: 26424679
[TBL] [Abstract][Full Text] [Related]
60. Vascular access site complications after percutaneous transfemoral aortic valve implantation.
Kahlert P; Al-Rashid F; Weber M; Wendt D; Heine T; Kottenberg E; Thielmann M; Kühl H; Peters J; Jakob HG; Sack S; Erbel R; Eggebrecht H
Herz; 2009 Aug; 34(5):398-408. PubMed ID: 19711036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
